Retatrutide (research code LY3437943) is a single-molecule triple agonist that activates the GIP receptor, the GLP-1 receptor, and the glucagon receptor
Step 3: Fill in Prescriber Information After filling out the patient information, fill out your prescriber information in the section below it
And for anyone for whom maximum weight loss is the priority, the injectables Mounjaro and Wegovy still set the pace
Comparing Retatrutide and Tirzepatide: Differences and Considerations Both Retatrutide and tirzepatide are developed by Eli Lilly and belong to the incretin-based family
Additionally, these products slow the speed of stomach emptying, extending the feeling of a full stomach and curbing the appetite, amongst other effects in the body
Pardon Our Interruption As you were browsing something about your browser made us think you were a bot